Monoclonal Antibodies
Anti-FGF23 Rabbit Monoclonal Antibody for WB, IF/ICC, ELISA - Q9GZV9
Item Number : CM0007624
Price varies based on specs and customizations
- Application
- WB, IF/ICC, ELISA
- Cross Reactivity
- Human
- Protein Weight
- 28kDa
Shipping:
Contact us to get shipping details Enjoy On-time Dispatch Guarantee.
Why Choose Us
Easy ordering process, quality products, and dedicated support for your business success.
Core Product Specifications and Parameters
| Parameter | Value |
|---|---|
| Product Name | FGF23 Rabbit mAb |
| Remarks/Alias | ADHR; FGFN; HYPF; HFTC2; HPDR2; PHPTC; FGF23 |
| Species | Human |
| GeneID (human) | 8074 |
| GeneID | 8074 |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 25-251 of human FGF23 (NP_065689.1) |
| Source | Rabbit |
| Category | Monoclonal Antibodies |
| Application | WB, IF/ICC, ELISA |
| Cross Reactivity | Human |
| SWISS | Q9GZV9 |
| Protein Weight | 28kDa |
| Shipping | Ice bag |
Biological Background: Fibroblast growth factor 23 Function and Localization
- FGF23 is a critical endocrine regulator of phosphate homeostasis, controlling renal phosphate excretion. Related references: PMID:11062477
- It inhibits renal tubular phosphate transport by downregulating SLC34A1 expression. Related references: PMID:11409890
- The protein also modulates vitamin D metabolism, contributing to systemic mineral balance. Related references: PMID:15040831
- In the presence of α-Klotho, FGF23 up-regulates EGR1 and directly suppresses parathyroid hormone secretion from the parathyroid gland.
- FGF23 negatively regulates osteoblast differentiation and bone matrix mineralization, linking bone remodeling to phosphate handling. Related references: PMID:18282132
- It is predominantly expressed by osteocytes and osteogenic cells in bone and is secreted into the bloodstream.
- Post-translational modifications include glycosylation and phosphorylation, and it possesses a signal peptide and disulfide bonds essential for its structure.
- Mutations in FGF23 cause human diseases such as autosomal dominant hypophosphatemic rickets (ADHR) and hyperphosphatemic familial tumoral calcinosis (HFTC2), reflected in its alternate names.
Experimental Guidance and Technical Tips
- For Western blotting, the predicted molecular weight is approximately 28 kDa; validate the observed band in your sample system and consider using appropriate positive controls.
- In immunofluorescence/immunocytochemistry (IF/ICC), human osteoblast or osteocyte cell lines may serve as suitable positive controls; optimize fixation and permeabilization conditions.
- For ELISA applications, pairing with a suitable detection antibody may be necessary; perform assay optimization according to your protocol.
- Since this monoclonal antibody was raised against a recombinant fragment covering the mature protein, it may detect both full-length and processed forms; confirm specificity in your experimental model.
CamelBio: Your One-Stop Sourcing Bridge
CamelBio provides diagnostic manufacturers and research laboratories with comprehensive access to validated antibodies, including this anti-FGF23 monoclonal antibody, for studying phosphate regulation and bone metabolism. Our portfolio includes optimized monoclonal/polyclonal antibodies, recombinant proteins, and ancillary reagents to support assay development. For rare or specialized targets, we offer custom sourcing and technical consultancy from concept to clinical application.
Product Datasheet
Anti-FGF23 Rabbit Monoclonal Antibody for WB, IF/ICC, ELISA - Q9GZV9
REQUEST A QUOTE
Our professional team will reply to you within one business day. Please feel free to contact us!